FIELD: chemistry.
SUBSTANCE: invention relates to novel optically active phenylthanolamine compounds of formula (I) having a (-)-configuration, or pharmaceutically acceptable salts thereof, which have β2-receptor agonist effect and can be used to treat asthma or bronchitis. In formula (I) R1 is H or halogen; R2 is CF3, CN or halogen; R3 is a straight or branched alkyl, having 1-6 carbon atoms or a cycloalkyl having 3-6 carbon atoms.
EFFECT: high efficiency of using the agents.
9 cl, 1 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
0 |
|
SU525423A3 | |
0 |
|
SU522793A3 | |
0 |
|
SU519126A3 | |
0 |
|
SU520036A3 | |
0 |
|
SU518122A3 | |
0 |
|
SU516344A3 | |
0 |
|
SU533335A3 | |
0 |
|
SU504478A3 | |
NEW PHENYLETHANOLAMINE COMPOUNDS AS AGONISTS OF BETA2-RECEPTOR AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2264382C1 |
0 |
|
SU519125A3 |
Authors
Dates
2011-04-20—Published
2007-07-02—Filed